-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
ReShape Lifesciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q4 2024.
- ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $15K, a 86.5% decline year-over-year.
- ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $184K, a 76% decline year-over-year.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2024 was $184K, a 76% decline from 2023.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $766K, a 63.3% decline from 2022.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.09M, a 82.9% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)